NCT01066052View on ClinicalTrials.gov

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

PHASE4CompletedINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

February 29, 1992

Primary Completion Date

March 31, 1999

Study Completion Date

August 31, 2010

Conditions

Turner's Syndrome

Interventions

DRUG

r-hGH

Subcutaneous administration.

Trial Locations (1)

75935

Hôpital Robert Debré, Paris

All Listed Sponsors

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01066052 - Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years | Biotech Hunter | Biotech Hunter